Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Hereditary α-tryptasemia is associated with anaphylaxis to antibiotics and monoclonal antibodies
Avtorji:ID Korošec, Peter, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Lyons, Jonathan J. (Avtor)
ID Svetina, Manca, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Koudová, Monika (Avtor)
ID Bittóová, Martina (Avtor)
ID Zidarn, Mihaela, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Sedláčková, Lenka (Avtor)
ID Rijavec, Matija, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Kopač, Peter, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S2213219825003691
 
.pdf PDF - Predstavitvena datoteka, prenos (733,20 KB)
MD5: CD374FFE205E3F910EF21E81088A3AE6
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Background Hereditary α-tryptasemia, a genetic trait caused by increased α-tryptase copy number, is associated with idiopathic and venom anaphylaxis. Objective We aimed to determine the impact of tryptase genotypes on drug-induced anaphylaxis. Methods A prospective discovery cohort of 99 patients from a referral center in Slovenia with acute anaphylaxis to drugs underwent tryptase genotyping by droplet digital PCR. For validation, we included a cohort of 26 patients from the Czech Republic. Associated inciting agents and the severity of the reactions were subsequently examined. Results Hereditary α-tryptasemia was associated with drug-induced anaphylaxis with a prevalence of 13% (n = 13 of 99) in the discovery cohort and 15% in the validation cohort (n = 4 of 26). Hereditary α-tryptasemia was identified in every individual with elevated basal serum tryptase levels (11.6-21.9 ng/mL; n = 14) within both cohorts of patients. Hereditary α-tryptasemia was more prevalent in individuals with antibiotic- or mAb-induced anaphylaxis in both the discovery and validation cohorts (n = 13 of 51; 26%) compared to those with anaphylaxis resulting from neuromuscular blocking agents, nonsteroidal anti-inflammatory drugs, contrast, chlorhexidine, or other drugs (n = 5 of 74; 7%; P = .02; odds ratio = 4.1; 95% CI, 1.3-11.1). Overall, we found fewer individuals with no ⍺-tryptase than in the general population, and there was a trend for subjects with more ⍺-tryptase copies to have more severe reactions. Thus, among subjects with three ⍺-tryptase copies, the prevalence of severe anaphylaxis was 73%, compared with 59% with one to two ⍺-tryptase copies and 58% for subjects without ⍺-tryptase. Conclusions Risk for anaphylaxis to antibiotics and biologics is associated with inherited differences in α-tryptase–encoding copies at Tryptase α/β1 .
Ključne besede:immunology, drug allergy, anaphylaxis, antibiotics, monoclonal antibodies, α-tryptase, hereditary α-tryptasemia
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:02.10.2024
Datum sprejetja članka:07.04.2025
Datum objave:17.04.2025
Založnik:Elsevier, 2013-
Leto izida:2025
Št. strani:str. 1449-1456.e4
Številčenje:Vol. 13, iss. 6
Izvor:The journal of allergy and clinical immunology. In practice
PID:20.500.12556/DiRROS-22721 Novo okno
UDK:616-097
ISSN pri članku:2213-2201
DOI:10.1016/j.jaip.2025.04.013 Novo okno
COBISS.SI-ID:233461507 Novo okno
Avtorske pravice:© 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 22. 4. 2025;
Datum objave v DiRROS:18.06.2025
Število ogledov:465
Število prenosov:251
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:The journal of allergy and clinical immunology : In practice
Založnik:Elsevier
ISSN:2213-2201
COBISS.SI-ID:2048298353 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0360
Naslov:Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-3072
Naslov:Dedni dejavniki anafilaksije povezani s povečanim številom α-triptaza kodirajoče sekvence TPSAB1

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:17.04.2025
Vezano na:Version of Record valid from 2025-04-17

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:imunologija, alergije, antibiotiki, dednost, monoklonska protitelesa


Nazaj